+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
CytoDyn Inc - logo

CytoDyn is a biotechnology company focused on the clinical development and potential commercialization of humanized monoclonal antibodies for the treatment and prevention of Human Immunodeficiency Virus (HIV) infection. The company has one of the leading monoclonal antibodies under development for HIV infection, PRO 140, which has finished Phase 2 clinical trials with demonstrated antiviral activity in man. The company is based in Vancouver, Washington.

From
From
From
From
From
From
From
From
From
From
Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2020 - Product Thumbnail Image

Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 770 pages
From
From
Psoriasis - Pipeline Review, H2 2020 - Product Thumbnail Image

Psoriasis - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 956 pages
From
Liver Cancer Global Clinical Trials Review, H1, 2020 - Product Thumbnail Image

Liver Cancer Global Clinical Trials Review, H1, 2020

  • Clinical Trials
  • January 2020
  • 2099 pages
From
Prefilled Syringes Market (5th Edition), 2020-2030 - Product Thumbnail Image

Prefilled Syringes Market (5th Edition), 2020-2030

  • Report
  • January 2020
  • 554 Pages
From
From
Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2020 - Product Thumbnail Image

Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 693 pages
From
From
Loading Indicator
adroll